Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Incretin hormones and the satiation signal
2013
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
2013
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
2013
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
2009
Impairment of health and quality of life in people with large waist circumference
1998
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Predicting intra-abdominal fatness from anthropometric measures: the influence of stature
1997
Progress and challenges in anti-obesity pharmacotherapy
2017
Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
2002
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
2013 Standout
Management of obesity
2016
Obesity and Diabetes in the Developing World — A Growing Challenge
2007 Standout
Future directions for peptide therapeutics development
2013
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
2000
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study
2005
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
2022
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies
2003
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Weight loss causes increased mortality: cons
2003
Obesity
2005 Standout
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
2015
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Type 2 diabetes
2017 Standout
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension
2012
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Management of obesity: improvement of health-care training and systems for prevention and care
2015
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Is the Relationship between Adipose Tissue and Waist Girth Altered by Weight Loss in Obese Men?
2001
Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity
2003
Obesity as a medical problem
2000 StandoutNature
Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
2018
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
2010
What We Talk About When We Talk About Fat
2014 Standout
New Medications for Treatment of Obesity: Metabolic and Cardiovascular Effects
2014
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Prevalence and Trends in Obesity Among US Adults, 1999-2000
2002 Standout
Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials
2019
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2019 Standout
Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
2000
European Guidelines for Obesity Management in Adults
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
The U-shaped association between body mass index and mortality: Relationship with weight gain in a native American population
1995
Maternal mortality: who, when, where, and why
2006 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum
2016
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Intentional weight loss and mortality among overweight individuals with diabetes.
2000
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
2013
Cardiovascular Biology of the Incretin System
2012
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
2016
Current and emerging medications for overweight or obesity in people with comorbidities
2015
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Type 2-diabetes og det metaboliske syndrom - diagnostik og behandling
2000
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
2015
The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
2013
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Versatile Peptide C-Terminal Functionalization via a Computationally Engineered Peptide Amidase
2016 StandoutNobel
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
2015
The Science of Obesity Management: An Endocrine Society Scientific Statement
2018
Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care.
1999
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Long-term Drug Treatment for Obesity
2013
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2015
Cardiovascular Actions of Incretin-Based Therapies
2014
Cardiovascular and Metabolic Heterogeneity of Obesity
2018
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults
2018
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of MEJ Lean being referenced
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
2011
Obesity, Weight Loss and Prognosis in Type 2 Diabetes
1990
Waist circumference reduction and cardiovascular benefits during weight loss in women
1997
PRESCRIPTION OF DIABETIC DIETS IN THE 1980s
1986